Cagrilintide
Updated April 28, 2026
Primary Benefits:
- Suppresses appetite by mimicking amylin
- Enhances satiety and reduces caloric intake
- Improves insulin sensitivity and metabolic health
- Complements GLP-1 agonists for synergistic fat loss
Mechanism of Action:
Cagrilintide is an amylin analogue that activates amylin receptors in the brainβs appetite-regulation centers. It slows gastric emptying, promotes feelings of fullness, and helps regulate postprandial glucose. It is often combined with GLP-1 receptor agonists for enhanced weight-loss efficacy.
Subcutaneous (SQ) Injection using a 30-31 gauge 6-8mm insulin syringe
β’ Reconstitution:
ββ 5 mg vial β 2.0 ml bacteriostatic water
ββ 10 mg vial β 2.0 ml bacteriostatic water
β’ Weekly Dose:
ββ 5 mg vial β 250β500 mcg (10β20 units)
ββ 10 mg vial β 250β500 mcg (5β10 units)
β’ Cycle:
ββ Once weekly.
ββ Begin with 250β500 mcg once per week for 4 weeks.
ββ Then titrate up by 500-1000 mcg (0.5β1 mg) weekly, if needed.
ββ Do not exceed 2500 mcg (2.5 mg) per week.
β’ Timing:
- Administer in the morning on the same day each week to maintain steady plasma levels.
- Take on the same day and time each week for stable blood levels.
Potential Side Effects:
- Mild nausea or fullness during the first few weeks
- Constipation or delayed gastric emptying
- Injection site irritation (rare)
- Not recommended for those with a history of pancreatitis
Common Stacks:
- With Tirzepatide or Semaglutide: Enhanced fat loss and appetite suppression
- With 5-Amino-1MQ: For metabolic acceleration and energy optimization
- With MOTS-c: For mitochondrial and endurance support
Notes:
Cagrilintide is most effective when used alongside dietary awareness and physical activity. It works best in combination with other peptide-based or GLP-1βbased interventions. Store reconstituted vials in the refrigerator and use within 45 days unless the product label or protocol says otherwise.
Disclaimer:
The information provided in this article is for educational and informational purposes only and is not intended as medical advice. These statements have not been evaluated by the FDA or Health Canada. Peptides and other compounds discussed are intended for research purposes only and are not approved for human consumption unless prescribed by a licensed medical professional. Always consult your healthcare provider before starting any new protocol, supplement, or treatment.
